Raymond James cuts Canadian National Railway to market perform; target to C$195
CNI•Raymond James cut its rating on Canadian National Railway to market perform from outperform and lowered its price target to C$195 from C$200.
Related News
FDA accepts UroGen's UGN-103 application for bladder cancer treatment
URGN•
BrasilAgro announces annual and extraordinary shareholders meeting
LND•
B. Riley raises Cinemark target price to $42 from $37
CNK•
Calidi's CLD-401 shows high rates of complete tumor eradication in mice
CLDI•
RedHill partner wins $2.9 million NCI grant for opaganib-CAR T trials in multiple myeloma
RDHL•